Supernus Pharmaceuticals reported $37.65M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Abbott USD 5.27B 834M Jun/2025
ANI Pharmaceuticals USD 97.9M 24.86M Jun/2025
Aurora Cannabis CAD 70.07M 8.78M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Canopy Growth CAD 54.1M 3.44M Jun/2025
Corcept Therapeutics USD 3.43M 1.03M Jun/2025
Eisai JPY 42.6B 2B Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
Novo Nordisk 12.85B 44M Jun/2025
Pacira USD 55.19M 20.88M Jun/2025
Perrigo USD 693.4M 41.8M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Supernus Pharmaceuticals USD 37.65M 21.88M Jun/2025
United Therapeutics USD 175.2M 102.3M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025